Aegerion

Have These 4 Biotechs Peaked?
Motley Fool
Mon, 09/16/13 - 11:04 am
biotech
Alexion
Pharmacyclics
Aegerion
Raptor Pharmaceuticals
Why Aegerion Is Worth 1,732 Times Sales
Seeking Alpha
Wed, 06/12/13 - 08:50 am
Aegerion
Juxtapid
Aegerion Continues To Gain Momentum As Analysts Raise Price Targets
Seeking Alpha
Thu, 05/30/13 - 04:49 pm
Aegerion
Juxtapid
Aegerion Pharmaceuticals Earnings Preview: Can This Streak Finally End?
Wall Street Cheat Street
Sat, 04/27/13 - 10:10 am
Aegerion
earnings
2 Orphan Drugmakers With Upcoming Catalysts
Seeking Alpha
Wed, 04/24/13 - 04:46 pm
orphan drugs
Raptor Pharmaceuticals
Aegerion
Juxtapid
procysbi
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Aegerion stock continues to climb after full-year financials
Bizjournals.com
Thu, 03/7/13 - 11:35 am
Aegerion
earnings
4 Can't-Miss Health-Care Events This Week
Motley Fool
Mon, 03/4/13 - 10:46 am
Depomed
FDA
Serada
Breo Ellipta
COPD
GSK
Theravance
Aegerion
Sarepta
Aegerion Pharmaceuticals Expected To Take A Hit
Seeking Alpha
Sat, 02/2/13 - 12:05 pm
Aegerion
Better Cancer Treatment: Partnerships and Dividends
The Motley Fool
Sat, 01/19/13 - 12:12 pm
cancer
treatment
Isis Pharmaceuticals
Aegerion
Astra Zeneca
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
Better Than Lipitor! Higher Sales?
Motley Fool
Tue, 01/1/13 - 11:53 am
Pfizer
Lipitor
Juxtapid
Aegerion
Kynamro
Sanofi
Isis Pharmaceuticals
Regeneron
Alnylam
PCSK9 inhibitors
Why Aegerion Keeps Winning
Motley Fool
Sat, 12/29/12 - 09:59 am
Aegerion
Several Reasons Why I'm Considering These 2 Biotech Firms Before Year's End
Seeking Alpha
Wed, 12/26/12 - 09:21 pm
Raptor Pharmaceuticals
Aegerion
Aegerion says FDA approves Juxtapid, a treatment for a rare high cholesterol disorder
Yahoo/AP
Mon, 12/24/12 - 10:30 am
lomitapide
Homozygous Familial Hypercholesterolemia
Juxtapid
Aegerion
FDA
Aegerion Hits New High
Motley Fool
Sat, 12/15/12 - 12:54 pm
Aegerion
lomitapide
Homozygous Familial Hypercholesterolemia
cholesterol
New drug holds promise as therapy for rare and deadly cholesterol disorder
Equities.com
Sun, 11/4/12 - 10:43 am
lomitapide
hypercholesterolemia
Aegerion
Aegerion's Lomitapide - FDA Approval, Strong Launch, Stock Price Increase Anticipated
Seeking Alpha
Wed, 10/24/12 - 10:58 am
lomitapide
FDA
Aegerion
Homozygous Familial Hypercholesterolemia
This Week in Biotech
Motley Fool
Sun, 10/21/12 - 10:47 am
Aegerion
Isis Pharmaceuticals
Sanofi
NPS Pharmaceuticals
Aeterna Zentaris
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 10/20/12 - 10:43 am
Siemens
Aegerion
Given Imaging

Pages